DimenhyDRINATE
Pronunciation
(dye men HYE dri nate)
U.S. Brand Names
Dramamine® [OTC]; TripTone® [OTC]
Generic Available
Yes
Canadian Brand Names
Apo-Dimenhydrinate®; Gravol®; Novo-Dimenate
Use
Treatment and prevention of nausea, vertigo, and vomiting associated with motion sickness
Pregnancy Risk Factor
B
Contraindications
Hypersensitivity to dimenhydrinate or any component
Warnings/Precautions
Causes sedation, caution must be used in performing tasks which require alertness (eg, operating machinery or driving). Sedative effects of CNS depressants or ethanol are potentiated. Use with caution in patients with angle-closure glaucoma, pyloroduodenal obstruction (including stenotic peptic ulcer), urinary tract obstruction (including bladder neck obstruction and symptomatic prostatic hyperplasia), hyperthyroidism, increased intraocular pressure, and cardiovascular disease (including hypertension and tachycardia). May cause paradoxical excitation in pediatric patients, and can result in hallucinations, coma, and death in overdose.
Adverse Reactions
>10%:
Central nervous system: Slight to moderate drowsiness
Respiratory: Thickening of bronchial secretions
1% to 10%:
Central nervous system: Headache, fatigue, nervousness, dizziness
Gastrointestinal: Appetite increase, weight gain, nausea, diarrhea, abdominal pain, xerostomia
Neuromuscular & skeletal: Arthralgia
Respiratory: Pharyngitis
Drug Interactions
Increased effect/toxicity with CNS depressants, anticholinergics, TCAs, MAO inhibitors
Increased toxicity of antibiotics, especially aminoglycosides (ototoxicity)
Ethanol/Nutrition/Herb Interactions
Ethanol: Avoid ethanol (may increase CNS depression).
Mechanism of Action
Competes with histamine for H1-receptor sites on effector cells in the gastrointestinal tract, blood vessels, and respiratory tract; blocks chemoreceptor trigger zone, diminishes vestibular stimulation, and depresses labyrinthine function through its central anticholinergic activity
Pharmacodynamics/Kinetics
Onset of action: Oral: ~15-30 minutes
Absorption: Oral: Well absorbed
Dosage
Oral:
Children:
2-5 years: 12.5-25 mg every 6-8 hours, maximum: 75 mg/day
6-12 years: 25-50 mg every 6-8 hours, maximum: 150 mg/day
Adults: 50-100 mg every 4-6 hours, not to exceed 400 mg/day
Dietary Considerations
May be taken with food or water.
Patient Education
May cause drowsiness, may impair judgment and coordination; avoid alcohol; drink plenty of fluids for dry mouth and to prevent constipation
Dental Health: Effects on Dental Treatment
Key adverse event(s) related to dental treatment: Significant xerostomia (normal salivary flow resumes upon discontinuation).
Dental Health: Vasoconstrictor/Local Anesthetic Precautions
No information available to require special precautions
Mental Health: Effects on Mental Status
Drowsiness is common; may cause depression, nervousness, or paradoxical CNS stimulation
Mental Health: Effects on Psychiatric Treatment
Concurrent use with psychotropic may result in additive sedation
Dosage Forms
Caplet (TripTone®): 50 mg
Tablet (Dramamine®): 50 mg
Tablet, chewable (Dramamine®): 50 mg [contains phenylalanine 1.5 mg/tablet and tartrazine; orange flavor]
International Brand Names
Amosyt® (SE); Anautin® (EC); Anautin SAD® (DK); Antemin® (CH); Anti-Em® (TR); Antimo® (ID); Apo-Dimenhydrinate® (CA, SG); Aviomarin® (PL); Biodramina® (ES, GT, SV); Cinfamar® (ES); Contramareo® (ES); Daedalon® (HU); Dekatravel® (BE); Denim® (TH); Dimenate® (HK, SG); Dimen Heumann® (DE); Dimenidrinato® (IT); Dimen Lichtenstein® (DE); Dimeno® (TH); Dimigal® (YU); Dimin® (TH); Dramamine® (AR, AU, BE, CY, EG, FR, HK, ID, IE, IL, IN, JO, KW, LB, LU, MT, MX, NL, PT, SG, SY, TH, TR, ZA); Dramanyl® (HN, SV); Dramavit® (BR); Dramavol® (GT, HN, PA, SV); Dramina® (HR, RU); Dramin® (BR); Dramnate® (IN); Emedyl® (AT); Enjomin® (PT); Gravol® (CA, HK, IN, TH); Lomarin® (IT); Mareamin® (CL); Mareol® (CO); Motivan® (TH); Motozina® (IT); Nausicalm® (FR); Navamin® (TH); Novo-Dimenate (CA); Paranausine® (BE, LU); Pasedol® (CO); Reisegold® (DE); Reisetabletten® (DE); Reisetabletten Lünopharm® (DE); Reisetabletten-ratiopharm® (DE); Reisetabletten Stada® (DE); Rodavan® (DE); RubieMen® (DE); Solbrine® (CH); Superpep® (DE); Travamin® (IL); Travel-Gum® (AT, CZ, IT); Travel Well® (ES); Trawell® (CH); Vagomine® (BE, LU); Valontan® (IT); Vertigo-Vomex® (DE); Vertirosan® (AT); Viabom® (PT); Vomacur® (DE); Vomex A® (DE); Vomidrine® (PT); Vominar® (TH); Vomisin® (MX); Xamamina® (IT, TR)
|
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's
accreditation program
is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s
editorial process
. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
|
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-2007
A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.